[Bevacizumab therapy for Poems syndrome].

Polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes (POEMS) syndrome refractory to complete serum vascular endothelial growth factor (VEGF) blockade: insights from sequential VEGF monitoring. NDT Plus (2009) 0.75

Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet (1998) 4.72

A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood (1999) 2.98

Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. Blood (1998) 2.71

Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol (1995) 2.37

Heterogeneous bullous pemphigoid antibodies: detection and characterization by immunoblotting when absent by indirect immunofluorescence. J Invest Dermatol (1989) 2.25

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group. N Engl J Med (1995) 1.94

Leg ulcers and hydroxyurea: forty-one cases. Arch Dermatol (1999) 1.77

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab. Ann Oncol (2004) 1.59

Disseminated microsporidiosis due to Septata intestinalis in patients with AIDS: clinical features and response to albendazole therapy. J Infect Dis (1995) 1.50

Thymoma-associated pancytopenia: effectiveness of cyclosporine A. Ann Hematol (1998) 1.47

A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia. J Clin Oncol (1991) 1.42

Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association. Leukemia (2012) 1.42

Comparison of Tc-99m-labelled antileukocyte fragment Fab' and Tc-99m-HMPAO leukocyte scintigraphy in the diagnosis of bone and joint infections: a prospective study. Nucl Med Commun (2000) 1.41

Role of drug exposure in aphthous ulcers: a case-control study. Br J Dermatol (2000) 1.39

New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1/S-phase transition. Leukemia (2008) 1.37

Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial. Br J Haematol (2000) 1.37

Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group. Leukemia (2000) 1.31

Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly. J Clin Oncol (1990) 1.30

Non-Hodgkin malignant lymphomas and peripheral neuropathies--13 cases. Brain (1995) 1.29

Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique. Arch Dermatol (1989) 1.21

Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France. J Clin Microbiol (2000) 1.18

Bier's white spots associated with scleroderma renal crisis. Clin Exp Dermatol (2006) 1.17

L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature. Ann Oncol (2008) 1.13

Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. J Clin Oncol (2004) 1.13

Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience. Leukemia (2003) 1.13

IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas. Leukemia (2012) 1.11

High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies. Cancer Res (1998) 1.09

Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study. Leukemia (2006) 1.07

Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years. J Clin Oncol (1997) 1.06

[Historic malignant tumour: 27 observations]. Ann Dermatol Venereol (2011) 1.06

Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura. Br J Haematol (2006) 1.02

Real-time PCR for quantification of human herpesvirus 6 DNA from lymph nodes and saliva. J Clin Microbiol (2002) 0.99

Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J Invest Dermatol (1997) 0.99

Dermatomyositis and malignancy. J Invest Dermatol (1993) 0.98

[Giant buccal aphthosis caused by nicorandil]. Presse Med (1997) 0.96

Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis. Arch Dermatol (1990) 0.96

Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial. Br J Dermatol (2012) 0.96

Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions. Br J Dermatol (2004) 0.96

Hepatitis C virus and Sjögren's syndrome. Arthritis Rheum (1993) 0.95

In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients. J Neuroimmunol (2000) 0.95

Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma. Leukemia (2004) 0.95

Identification of the Rochalimaea henselae 16S rRNA sequence in the liver of a French patient with bacillary peliosis hepatis. J Infect Dis (1992) 0.94

[Anticytoplasmic antibodies of human epidermal cells (author's transl)]. Ann Dermatol Venereol (1977) 0.93

Herpes simplex esophagitis in patients with AIDS: report of 34 cases. The Cooperative Study Group on Herpetic Esophagitis in HIV Infection. Clin Infect Dis (1996) 0.93

Melorheostosis with associated minimal change nephrotic syndrome, mesenteric fibromatosis and capillary haemangiomas. Dermatology (1994) 0.93

Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations. Hum Pathol (2001) 0.92

Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: a retrospective, longitudinal survey (MELODY study). Eur J Cancer (2012) 0.91

Molecular study of an IgG1kappa cryoglobulin yielding organized microtubular deposits and glomerulonephritis in the course of chronic lymphocytic leukaemia. Clin Exp Immunol (2002) 0.91

Oral nicorandil-induced lesions are not aphthous ulcers. J Oral Pathol Med (2003) 0.91

Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS. Leuk Res (2011) 0.90

Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trial. Blood (2000) 0.89

Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B). Ann Oncol (2012) 0.89

The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita. J Invest Dermatol (1991) 0.89

[Cutaneous drug reactions induced by glycopeptides]. Med Mal Infect (2007) 0.88

Hodgkin's disease after transplantation. Transplantation (1996) 0.88

Skin antibodies in bone marrow transplanted patients. Clin Exp Dermatol (1976) 0.88

[Bacterial dermo-hypodermatitis in adults. Incidence and role of streptococcal etiology]. Ann Dermatol Venereol (1995) 0.88

Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study). Eur J Cancer (2012) 0.88

[Immunofluorescence in temporal arteritis]. N Engl J Med (1978) 0.87

Chlorambucil-associated pneumonitis. Chest (1994) 0.87

Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol (1996) 0.86

Synthesis and in vitro and in vivo antimalarial activity of new 4-anilinoquinolines. J Med Chem (2001) 0.85

Cervicofacial hemangioma and a minor sternal malformation: inclusion in PHACES syndrome? Pediatr Dermatol (1998) 0.85

[Diabetes insipidus revealing primary malignant non-Hodgkin's lymphoma of bone]. Rev Med Interne (1998) 0.85

Treatment of verrucous carcinoma with recombinant alfa-interferon. Dermatology (1995) 0.85

Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial). Leukemia (1999) 0.85

Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT). Ann Oncol (2014) 0.85

[Drug hypersensitive syndrome caused by fluindione]. Ann Dermatol Venereol (2001) 0.84

Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients. J Eur Acad Dermatol Venereol (2010) 0.84

Acquired ichthyosis and pyoderma gangrenosum in a patient with systemic lupus erythematosus. Clin Exp Dermatol (1993) 0.84

Aortic insufficiency and recurrent valve prosthesis dehiscence in MAGIC syndrome. J Rheumatol (1993) 0.84

High prevalence and risk factors of thromboembolism in stage IV melanoma. J Eur Acad Dermatol Venereol (2011) 0.84

Postoperative interstitial radiotherapy of keloids by iridium 192: a retrospective study of 46 treated scars. Dermatology (1997) 0.83

Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte. J Clin Oncol (2000) 0.83

Urticarial vasculitis induced by fluoxetine. Dermatology (1995) 0.83

[Peripheral neuropathies and hemopathies]. Rev Med Interne (1993) 0.83

[Physiopathology of bullous pemphigoid]. Ann Dermatol Venereol (2009) 0.83

[Calciphylaxis treated by cinacalcet: a medical alternative to parathyroidectomy]. Rev Med Interne (2008) 0.83

[Methi-resistant Staphylococcus aureus in dermatological practice: origin, risk factors and outcome]. Ann Dermatol Venereol (2002) 0.83

Trypanothione reductase inhibition/trypanocidal activity relationships in a 1,4-bis(3-aminopropyl)piperazine series. Bioorg Med Chem (2000) 0.83

Familial aquagenic urticaria. Dermatologica (1979) 0.83

[Drug-induced hypersensitivity syndrome in internal medicine: diagnostic and therapeutic traps. Eight observations]. Rev Med Interne (2000) 0.82

[Treatment of malignant hemopathies with aracytine in low doses. Analysis of 159 cases]. Nouv Rev Fr Hematol (1985) 0.82

[Verrucous carcinoma of the lower limbs]. Ann Dermatol Venereol (2007) 0.82

Alopecia areata occurring in a patient receiving systemic cyclosporin A. Acta Derm Venereol (1994) 0.82

[Primary cutaneous large B-cell lymphoma in chronic venous leg ulcer]. Ann Dermatol Venereol (2007) 0.81

[Survival prognosis in pemphigoid. A cohort analysis of 78 patients]. Ann Dermatol Venereol (1995) 0.81

[Pemphigoid vegetans. An immunoelectron microscopic study]. Ann Dermatol Venereol (1997) 0.81

Immunoblot analysis of IgG subclasses of circulating antibodies in bullous pemphigoid. Clin Immunol Immunopathol (1990) 0.81

HLA-DRB1 and HLA-DQB1 genes in susceptibility and resistance to cicatricial pemphigoid in French Caucasians. Eur J Dermatol (1998) 0.81